2-[4-(2,6-difluoro-phenoxy)-6-oxo-6H-pyridazin-1-yl]-3-phenyl-propionic acid → 2-[4-(2,6-difluoro-phenoxy)-6-oxo-6H-pyridazin-1-yl]-N-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-3-phenyl-propionamide
Reaction equation
[F:1][C:2]1[CH:26]=[CH:25][CH:24]=[C:23]([F:27])[C:3]=1[O:4][C:5]1[CH:6]=[N:7][N:8]([CH:12]([CH2:16][C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=2)[C:13](O)=[O:14])[C:9](=[O:11])[CH:10]=1.[NH2:28][C:29]1[CH:33]=[CH:32][N:31]([CH2:34][C:35]([CH3:38])([OH:37])[CH3:36])[N:30]=1>>[F:1][C:2]1[CH:26]=[CH:25][CH:24]=[C:23]([F:27])[C:3]=1[O:4][C:5]1[CH:6]=[N:7][N:8]([CH:12]([CH2:16][C:17]2[CH:18]=[CH:19][CH:20]=[CH:21][CH:22]=2)[C:13]([NH:28][C:29]2[CH:33]=[CH:32][N:31]([CH2:34][C:35]([OH:37])([CH3:36])[CH3:38])[N:30]=2)=[O:14])[C:9](=[O:11])[CH:10]=1Participants
Reactant 2
Product 1
Procedure
Using the method described in Example 17 from 2-[4-(2,6-difluoro-phenoxy)-6-oxo-6H-pyridazin-1-yl]-3-phenyl-propionic acid (Intermediate 30) and 1-(3-amino-pyrazol-1-yl)-2-methyl-propan-2-ol (Intermediate 1) afforded 2-[4-(2,6-difluoro-phenoxy)-6-oxo-6H-pyridazin-1-yl]-N-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-3-phenyl-propionamide was obtained as a white solid (0.26 g, 34%); ES+-HRMS m/e calcd for C26H25N5O4F2 [M+H+] 510.1948 found 510.1949. 1H-NMR (400 MHz, DMSO-d6) δ ppm 1.06 (s, 3H) 1.07 (s, 3H) 3.35-3.56 (m, 2H) 3.91 (s, 2H) 4.67 (s, 1H) 5.81 (dd, J=10.7, 4.9 Hz, 1H) 5.92 (d, J=3.0 Hz, 1H) 6.44 (d, J=2.3 Hz, 1H) 7.10-7.20 (m, 1H) 7.24 (t, J=7.1 Hz, 2H) 7.29 (d, J=7.1 Hz, 2H) 7.32-7.40 (m, 2H) 7.40-7.50 (m, 1H) 7.55 (d, J=2.3 Hz, 1H) 8.24 (d, J=3.0 Hz, 1H) 11.00 (s, 1H).
Sources & evidence
- ORD record
- ord-aabe06c1337d4b52a64c82be4f1483a3
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08258134B2
Reaction notes
Loading…